Virtus Investment Advisers’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Virtus Investment Advisers's PGEN Position: Q2 2026 in Review
Virtus Investment Advisers increased its Precigen (PGEN) stake by 254% in Q2 2026, buying an estimated $810K and bringing the position to 261,322 shares worth $1.49M. The position accounts for 0.35% of the portfolio, ranked #120.
Virtus Investment Advisers first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Virtus Investment Advisers held 261,322 shares of Precigen worth $1.49M as of Q2 2026.
- Virtus Investment Advisers bought 187,423 Precigen shares in Q2 2026, an estimated $810K.
- Precigen made up 0.35% of Virtus Investment Advisers's portfolio in Q2 2026, its #120 holding.
- Virtus Investment Advisers first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.